Indian Pharmaceuticals & Biotech Healthy potentially undervalued

Results

1 new

Companies which are potentially undervalued and in an acceptable financial position.

2 companies

Alembic Pharmaceuticals

Market Cap: ₹163.0b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

APLLTD

₹829.05

6.2%

-16.1%

Piramal Pharma

Market Cap: ₹223.8b

Operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

PPLPHARMA

₹168.54

-2.3%

-17.5%